Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients

Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients

Abstract Background There is no agreed upon standard of care for borderline‐resectable pancreatic cancer (BRPC) or locally‐advanced pancreatic cancer (LAPC) patients regarding the benefit of chemotherapy or radiation alone or in combination. Patients and Methods We completed a retrospective cohort a...

Full description

Bibliographic Details
Main Authors: Gregory P. Botta, Tridu R. Huynh, Samantha R. Spierling‐Bagsic, Alexander Agelidis, Randolph Schaffer, Ray Lin, Darren Sigal
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
chemotherapy
pancreatic cancer
radiation
resection
Online Access:https://doi.org/10.1002/cam4.5523

Internet

https://doi.org/10.1002/cam4.5523

Similar Items